| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/08941939.2016.1238983 |
| P698 | PubMed publication ID | 27780379 |
| P2093 | author name string | Michael A Zimmerman | |
| Tae Kim | |||
| Kwan Soo Hong | |||
| Sang Mok Lee | |||
| Joohyun Kim | |||
| Johnny C Hong | |||
| David C Cronin | |||
| Hyeyoung Moon | |||
| Mark D Hohenwalter | |||
| In-Kyung Oh | |||
| P2860 | cites work | Tissue-specific MR contrast agents | Q30778784 |
| Cirrhotic Rat Liver: Reference to Transporter Activity and Morphologic Changes in Bile Canaliculi—Gadoxetic Acid–enhanced MR Imaging | Q33642605 | ||
| Effect of change in transporter expression on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging during hepatocarcinogenesis in rats | Q33823977 | ||
| Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition | Q37279800 | ||
| Posthepatectomy liver failure. | Q37996310 | ||
| Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging | Q38128706 | ||
| Assessment of hepatic function, operative candidacy, and medical management after liver resection in the patient with underlying liver disease | Q38128751 | ||
| Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver | Q38257546 | ||
| Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. | Q38303023 | ||
| Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC. | Q38835970 | ||
| Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. | Q39712719 | ||
| Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). | Q39793607 | ||
| Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. | Q43273414 | ||
| Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. | Q43452907 | ||
| Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis | Q44527583 | ||
| Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. | Q45810898 | ||
| Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes | Q46426726 | ||
| Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury | Q46686093 | ||
| It's all about bile | Q48493435 | ||
| P433 | issue | 4 | |
| P921 | main subject | hepatectomy | Q1514021 |
| P304 | page(s) | 265-271 | |
| P577 | publication date | 2016-10-26 | |
| P1433 | published in | Journal of Investigative Surgery | Q15749610 |
| P1476 | title | Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis | |
| P478 | volume | 30 |
Search more.